KIM AUSTIN D.
SEC CIK 1746240 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | EVP, GC, Sec | 46.9K | — | $496.3K | 18 | 2022-01-06 | 2024-01-08 |
Most active insiders at ACAD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneyer Mark C. | EVP, CFO | — | $1.13M |
| 2 | Daly James M | Dir | — | $671.1K |
| 3 | Kihara James | PRINCIPAL ACCOUNTING Off | — | $602.8K |
| 4 | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | — | $506.4K |
| 5 | Owen Adams Catherine | CEO, Dir | — | $249.9K |
| 6 | Rhodes Jennifer J | EVP, CLO, SEC | — | $245.0K |
| 7 | Ndu Adora | Dir | — | — |
| 8 | GAROFALO ELIZABETH A. | Dir | — | — |
| 9 | Poole Jonathan | Dir | — | — |
| 10 | Brege Laura | Dir | — | — |
KIM AUSTIN D. made no open-market trades at ACAD in the last 12 months.
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-09 | 2024-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +1,634 | 47.5K | +4% | — |
| D | 2024-01-09 | 2024-01-08 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $29.96 | -590 | 46.9K | -1% | -$17.7K |
| D | 2023-10-06 | 2023-10-05 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +36.2K | 62.2K | +139% | — |
| D | 2023-10-06 | 2023-10-06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $21.96 | -16.4K | 45.9K | -26% | -$359.5K |
| D | 2023-05-02 | 2023-04-29 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +3,005 | 26.4K | +13% | — |
| D | 2023-05-02 | 2023-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $21.18 | -917 | 25.5K | -3% | -$19.4K |
| D | 2023-04-07 | 2023-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +4,773 | 24.9K | +24% | — |
| D | 2023-04-07 | 2023-04-06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $18.16 | -1,456 | 23.4K | -6% | -$26.4K |
| D | 2023-02-27 | 2023-02-24 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $18.78 | -803 | 20.1K | -4% | -$15.1K |
| D | 2023-02-27 | 2023-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +2,214 | 20.9K | +12% | — |
| D | 2023-01-10 | 2023-01-09 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $17.13 | -589 | 18.7K | -3% | -$10.1K |
| D | 2023-01-10 | 2023-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +1,633 | 19.3K | +9% | — |
| D | 2022-05-03 | 2022-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | S - Sale+OE | $18.18 | -894 | 16.7K | -5% | -$16.3K |
| D | 2022-05-03 | 2022-04-29 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC, Sec | M - OptEx | — | +3,005 | 17.6K | +21% | — |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC | S - Sale+OE | $23.80 | -782 | 14.6K | -5% | -$18.6K |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC | M - OptEx | $0.00 | +2,213 | 15.4K | +17% | $0 |
| D | 2022-01-10 | 2022-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC | S - Sale+OE | $23.05 | -574 | 13.2K | -4% | -$13.2K |
| D | 2022-01-10 | 2022-01-06 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP, GC | M - OptEx | — | +1,633 | 13.8K | +13% | — |
Purchase Sale Sale after option exercise All abbreviations